Retail Pharmacy Recalls Sterile Compounded Drugs

Downing Labs, a retail pharmacy based in Texas, has issued a voluntary recall of all lots of sterile products.

The FDA noted that the pharmacy, which is responsible for compounding and packaging the items, is concerned with sterility assurance.

The items that qualify for recall were distributed in the United States between April 20, 2015, and September 15, 2015.

In the event that a patient uses a product within this lot, there is a risk for contamination and infection.

The recall does not apply to non-sterile compounded products from Downing.

Downing Labs recommends patients discontinue use of the products and set aside unused items until they receive information on how to return them.

Patients should contact their physicians if they believe they have experienced adverse effects from Downing Lab products.

Similarly, pharmacists should report any adverse effects related to the medications to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

Downing Labs has said that thus far, there have been no consumer complaints regarding the products.

According to Downing Labs’ website, the company ships prescriptions to more than 35 states.